Online citations, reference lists, and bibliographies.
← Back to Search

Approaches For Enhancing Oral Bioavailability Of Peptides And Proteins.

J. Renukuntla, A. D. Vadlapudi, Ashaben Patel, Sai H S Boddu, A. Mitra
Published 2013 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Oral delivery of peptide and protein drugs faces immense challenge partially due to the gastrointestinal (GI) environment. In spite of considerable efforts by industrial and academic laboratories, no major breakthrough in the effective oral delivery of polypeptides and proteins has been accomplished. Upon oral administration, gastrointestinal epithelium acts as a physical and biochemical barrier for absorption of proteins resulting in low bioavailability (typically less than 1-2%). An ideal oral drug delivery system should be capable of (a) maintaining the integrity of protein molecules until it reaches the site of absorption, (b) releasing the drug at the target absorption site, where the delivery system appends to that site by virtue of specific interaction, and (c) retaining inside the gastrointestinal tract irrespective of its transitory constraints. Various technologies have been explored to overcome the problems associated with the oral delivery of macromolecules such as insulin, gonadotropin-releasing hormones, calcitonin, human growth factor, vaccines, enkephalins, and interferons, all of which met with limited success. This review article intends to summarize the physiological barriers to oral delivery of peptides and proteins and novel pharmaceutical approaches to circumvent these barriers and enhance oral bioavailability of these macromolecules.
This paper references
10.1016/S0168-3659(02)00019-6
Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers.
M. Morishita (2002)
10.1211/002235702108
Poly(L‐lysine) as a model drug macromolecule with which to investigate secondary structure and microporous membrane transport, part 2: diffusion studies
Montakarn Chittchang (2002)
10.2174/092986710793205426
Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
S. Jana (2010)
10.1016/c2009-1-64521-4
Physiology of the Gastrointestinal Tract
L. Johnson (1994)
10.1021/JS990094E
Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
D. Liu (1999)
10.1016/J.JCONREL.2004.10.032
Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin-microparticle conjugates in oral insulin delivery system.
Byoung-Yun Kim (2005)
10.1023/A:1016008419367
Oral Controlled Release Technology for Peptides: Status and Future Prospects
J. Fix (2004)
A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit.
A. Yamamoto (1992)
10.1006/BBRC.1993.2487
Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.
P. Augustijns (1993)
10.3109/10717544.2010.522611
The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery
G. Millotti (2011)
10.1080/107175401300002711
In vivo absorption studies of insulin from an oral delivery system.
N. Jerry (2001)
10.1023/A:1018983511247
Development of New Lipophilic Derivatives of Tetragastrin: Physicochemical Characteristics and Intestinal Absorption of Acyl-tetragastrin Derivatives in Rats
T. Tenma (2004)
10.1016/0264-410X(93)90011-L
Biodegradable microparticles for oral immunization.
D. O'hagan (1993)
10.1517/17425247.2011.574121
Polysaccharides: a targeting strategy for colonic drug delivery
N. Shah (2011)
10.1016/j.jconrel.2008.09.076
Effect of cell-penetrating peptides on the nasal absorption of insulin.
E. Khafagy (2009)
10.1210/ENDO-65-1-118
Intestinal absorption of insulin in the rat.
E. Danforth (1959)
10.1016/S0169-409X(00)00063-6
Oral delivery of salmon calcitonin.
Y. H. Lee (2000)
10.1016/S0896-1549(02)00034-2
Novel approaches for retinal drug delivery.
D. Kurz (2002)
10.1016/j.ijpharm.2013.02.040
Skin penetration enhancers.
M. Lane (2013)
10.1016/B978-0-12-391860-4.00015-X
Chitosan-coated solid lipid nanoparticles for insulin delivery.
P. Fonte (2012)
10.1016/j.jconrel.2008.11.014
Complexation hydrogels for intestinal delivery of interferon beta and calcitonin.
N. Kamei (2009)
10.1021/JS970018G
Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon
H. Tozaki (1997)
10.1615/CRITREVTHERDRUGCARRIERSYST.V24.I1.30
Oral colon-specific drug delivery of protein and peptide drugs.
V. Sinha (2007)
10.1080/10611860600648221
Reversible lipidization for the oral delivery of leu-enkephalin
J. Wang (2006)
10.1016/j.jconrel.2009.02.015
Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides.
N. Kamei (2009)
10.1023/A:1018947430018
Passive Transepithelial Absorption of Thyrotropin-Releasing Hormone (TRH) via a Paracellular Route in Cultured Intestinal and Renal Epithelial Cell Lines
D. T. Thwaites (2004)
10.2217/nnm.12.38
Oral insulin: déjà vu?
I. Rubinstein (2012)
10.1111/j.2042-7158.1992.tb05463.x
Improvement of Large Intestinal Absorption of Insulin by Chemical Modification with Palmitic Acid in Rats
M. Hashizume (1992)
10.1021/CR000700M
Peroral route: an opportunity for protein and peptide drug delivery.
A. Sood (2001)
10.1016/S0169-409X(97)00045-8
Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies.
T Borchardt R (1997)
10.1016/j.ejpb.2010.02.011
A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery.
T. Gratieri (2010)
10.1002/jps.22560
Oral delivery system for two-pulse colonic release of protein drugs and protease inhibitor/absorption enhancer compounds.
M. D. Del Curto (2011)
10.1093/milmed/156.7.343
A comparison of median hearing thresholds from U.S. Navy and U.S. Army audiometric data bases.
C. D. Ridgley (1991)
10.1517/17425247.2011.597739
Cutting-edge technologies in colon-targeted drug delivery systems
M. Patel (2011)
10.1073/PNAS.0500062102
Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent.
Y. Bai (2005)
10.1016/j.bbrc.2010.03.041
Investigation of archaeosomes as carriers for oral delivery of peptides.
Z. Li (2010)
10.1016/0378-5173(90)90030-8
Intestinal mucosal transport of insulin
R. J. Schilling (1990)
10.1016/0005-2736(94)90035-3
Interaction of multidrug-resistant Chinese hamster ovary cells with the peptide ionophore gramicidin D.
D. Loe (1994)
Oral insulin delivery by means of solid lipid nanoparticles
B. Sarmento (2007)
10.1007/s11095-008-9816-8
Synthesis, Characterization and In Vivo Efficacy of PEGylated Insulin for Oral Delivery with Complexation Hydrogels
A. Tuesca (2008)
10.1016/S0169-409X(00)00127-7
The potential use of receptor-mediated endocytosis for oral drug delivery.
G. Russell-Jones (2001)
10.1016/j.yexmp.2008.12.004
Nanoparticle-based targeted drug delivery.
R. Singh (2009)
10.1113/jphysiol.1959.sp006125
The intestinal absorption of some dipeptides
H. Newey (1959)
10.1016/S0168-3659(03)00008-7
Reversible lipidization for the oral delivery of salmon calcitonin.
J. Wang (2003)
10.1016/S0168-3659(99)00042-5
Optimizing oral absorption of peptides using prodrug strategies.
R. Borchardt (1999)
10.1016/J.EJPS.2005.02.008
A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
M. Garcia-Fuentes (2005)
10.2174/156720108784911712
Colon targeted drug delivery systems--an overview.
P. Kumar (2008)
10.1023/A:1015885823793
Structural Specificity of Mucosal-Cell Transport and Metabolism of Peptide Drugs: Implication for Oral Peptide Drug Delivery
J. P. Bai (2004)
10.1016/0016-5085(92)90111-B
Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats.
S. Watanabe (1992)
10.1016/j.molmed.2012.04.012
Cell-penetrating peptides: breaking through to the other side.
E. Koren (2012)
10.1016/J.EJPB.2004.02.018
Chances and pitfalls of cell penetrating peptides for cellular drug delivery.
R. Tréhin (2004)
10.1080/10611860600648494
Colon-specific delivery and enhanced colonic absorption of [Asu1,7]-eel calcitonin using chitosan capsules containing various additives in rats
G. Fetih (2006)
10.1016/J.JCONREL.2005.05.001
Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs.
Ching J Lim (2005)
10.1023/A:1007514121527
Systematic Investigations of the Influence of Molecular Structure on the Transport of Peptides Across Cultured Alveolar Cell Monolayers
A. N. Dodoo (2004)
10.1016/j.ijpharm.2011.04.021
Mechanistic studies on the uptake and intracellular trafficking of novel cyclodextrin transfection complexes by intestinal epithelial cells.
Martin J O' Neill (2011)
10.2174/187221109788452221
Oral protein delivery: a patent review of academic and industrial approaches.
M. Werle (2009)
10.1038/nrd2468
Prodrugs: design and clinical applications
J. Rautio (2008)
10.2174/092986711795656243
The use of cyclodextrins nanoparticles for oral delivery.
J. Kanwar (2011)
10.1016/J.ADDR.2004.10.010
Cell-penetrating peptides: mechanism and kinetics of cargo delivery.
M. Zorko (2005)
10.1517/17425247.2.4.683
Role of efflux pumps and metabolising enzymes in drug delivery
Suresh Katragadda (2005)
10.4103/0250-474X.42967
Protein and Peptide Drug Delivery: Oral Approaches
J. Shaji (2008)
10.1016/0306-3623(91)90260-d
Biopharmaceutics and clinical pharmacokinetics
M. Gibaldi (1977)
10.2165/00063030-200519030-00003
Oral Delivery of Peptide Drugs
J. Hamman (2012)
10.1016/S0169-409X(02)00228-4
Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
J. Panyam (2003)
10.1201/9781498710565
Colloidal Drug Delivery Systems
J. Kreuter (1994)
10.1016/S0168-3659(97)00204-6
The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.
A. Bernkop-Schnürch (1998)
10.1023/A:1010936227570
Oral Delivery of Biologically Active Parathyroid Hormone
A. Leone-Bay (2004)
10.1211/jpp.58.2.0016
Paracellular and transcellular pathways facilitate insulin permeability in rat gut
M. Lane (2006)
10.1517/17425247.2012.682148
Chitosan: a potential polymer for colon-specific drug delivery system
A. Gulbake (2012)
10.1016/j.addr.2011.12.014
Oral biodrug delivery using cell-penetrating peptide.
E. Khafagy (2012)
10.1126/SCIENCE.3526553
A new approach to the oral administration of insulin and other peptide drugs.
M. Saffran (1986)
10.1002/BDD.302
The effect of enzyme inhibitor and absorption site following [D‐ala2, D‐leu5]enkephalin oral administration in rats
H. J. Lee (2002)
10.1016/j.ijpharm.2009.07.022
Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.
E. Khafagy (2009)
10.1016/J.JCONREL.2007.07.009
In situ-forming hydrogels for sustained ophthalmic drug delivery.
Basavaraj K Nanjawade (2007)
10.1016/S0304-4165(00)00051-9
Intestinal transport and metabolism of glucose-conjugated kyotorphin and cyclic kyotorphin: metabolic degradation is crucial to intestinal absorption of peptide drugs.
T. Mizuma (2000)
10.1016/S0378-5173(99)00331-2
In vitro assessment of archaeosome stability for developing oral delivery systems.
G. B. Patel (2000)
10.2337/DIACARE.26.2.421
Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.
M. Kipnes (2003)
10.1023/A:1018967116988
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
P. Artursson (2004)
10.1023/A:1015825912542
The Influence of Peptide Structure on Transport Across Caco-2 Cells
R. Conradi (2004)
10.1615/CRITREVTHERDRUGCARRIERSYST.V24.I2.20
Therapeutic opportunities in colon-specific drug-delivery systems.
M. Patel (2007)
10.1208/s12248-011-9307-4
Absorption Enhancers: Applications and Advances
B. Aungst (2011)
10.1111/j.1755-3768.1986.tb06923.x
A preliminary study of corneal penetration of 125l‐labelled idoxuridine liposome
S. Dharma (1986)
10.1002/1097-4636(20000905)51:3<329::AID-JBM6>3.0.CO;2-0
Biorecognition of HPMA copolymer-lectin conjugates as an indicator of differentiation of cell-surface glycoproteins in development, maturation, and diseases of human and rodent gastrointestinal tissues.
S. Wróblewski (2000)
10.1126/SCIENCE.285.5433.1569
In vivo protein transduction: delivery of a biologically active protein into the mouse.
S. Schwarze (1999)
10.1016/J.IJPHARM.2003.09.016
Vesicular systems in ocular drug delivery: an overview.
I. P. Kaur (2004)
Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines.
D. I. Jones (1997)
10.1016/j.addr.2012.10.007
Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
Yeonhee Yun (2013)
10.1021/JS950534B
Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.
T. Loftsson (1996)
10.1016/S0169-409X(00)00137-X
Delivery systems for penetration enhancement of peptide and protein drugs: design considerations.
U. B. Kompella (2001)
10.1016/J.ADDR.2004.07.014
Use of fluorescence imaging to investigate the structure and function of intestinal M cells.
A. Buda (2005)
10.4103/0975-7406.76478
Mucoadhesive drug delivery systems
Rahamatullah Shaikh (2011)
10.1007/s11095-006-9166-3
Interplay of Secondary Structure and Charge on the Diffusion of a Polypeptide through Negatively Charged Aqueous Pores
Montakarn Chittchang (2006)
10.1023/A:1018997101542
Cyclodextrins as Mucosal Absorption Promoters of Insulin. II. Effects of β-Cyclodextrin Derivatives on α-Chymotryptic Degradation and Enteral Absorption of Insulin in Rats
Z. Shao (2004)
10.1016/J.REACTFUNCTPOLYM.2010.10.002
Oral protein delivery: Current status and future prospect
K. Park (2011)
10.1007/s11095-005-9444-5
Magnetically Responsive Polymeric Microparticles for Oral Delivery of Protein Drugs
J. Cheng (2005)
10.1248/BPB1978.11.395
The effect of additives on the oral mucosal absorption of human calcitonin in rats.
Y. Nakada (1988)
10.1023/A:1016318423563
Controlled Release of Polypeptides and Other Macromolecules
R. Siegel (2004)
10.1016/j.ijpharm.2012.08.045
Preactivated thiomers: Permeation enhancing properties
X. Wang (2012)
10.1016/j.biomaterials.2011.10.075
Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Y. Jin (2012)
10.1080/10717540902937471
Insulin-loaded poly(acrylic acid)-cysteine nanoparticles: Stability studies towards digestive enzymes of the intestine
G. Perera (2009)
10.1023/A:1016113117851
Preparation and Characterization of Mono-PEGylated Epidermal Growth Factor: Evaluation of in Vitro Biologic Activity
H. Lee (2004)
Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties.
K. Peh (1999)
BASF Chairman Hambrecht Stands Behind Chemicals
M. Mccoy (2005)
10.1039/9781847557292
Amino-acids, Peptides, and Proteins
R. Sheppard (1976)
10.1016/j.ijpharm.2010.03.061
Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins.
Vellore J. Mohanraj (2010)
10.4103/0250-474X.95608
Noninvasive Routes of Proteins and Peptides Drug Delivery
Jitendra (2011)
10.1016/S0378-5173(02)00112-6
An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon.
H. Zhang (2002)
10.1208/pt060243
Cyclodextrins in drug delivery: An updated review
R. Challa (2008)
10.3109/03602538308991382
A comparison of thyrotropin-releasing hormone with analogs: influence of disposition upon pharmacology.
M. Hichens (1983)
10.1016/j.ejpb.2008.06.021
Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
P. F. Builders (2008)
10.1111/j.2042-7158.1996.tb05912.x
The Effects of Backing Materials and Multilayered Systems on the Characteristics of Bioadhesive Buccal Patches
J. H. Guo (1996)
10.1016/S1043-6618(03)00158-0
P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement.
M. Varma (2003)
10.1136/gut.35.4.441
Intestinal absorption of peptide drugs: advances in our understanding and clinical implications.
S. Catnach (1994)
10.1016/S0928-0987(99)00032-9
Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
N. G. Schipper (1999)
10.1126/SCIENCE.127.3306.1115
Effect of trypsin inhibitor on passage of insulin across the intestinal barrier.
M. Laskowski (1958)
10.1016/0169-409X(95)00131-P
The potential use of receptor-mediated endocytosis for oral drug delivery 1 PII of original article:
G. Russell-Jones (1996)
10.1089/152091502760306544
Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2.
S. Clement (2002)
10.1016/J.JCONREL.2007.10.023
Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes.
Nartaya Thirawong (2008)
10.1007/978-0-387-49785-3_2
Prodrug Approaches to Enhancing the Oral Delivery of Poorly Permeable Drugs
V. Stella (2007)
10.1016/S0168-3659(01)00269-3
Drug permeation enhancement via buccal route: possibilities and limitations.
S. Şenel (2001)
10.1016/J.IJPHARM.2005.01.022
Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium.
Nazila Salamat-Miller (2005)
10.1517/17425247.1.1.87
Thiomers for oral delivery of hydrophilic macromolecular drugs
A. Bernkop-Schnürch (2004)
10.2217/NNM.12.31
Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin.
S. Jain (2012)
10.1023/A:1018968611962
Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats
A. Yamamoto (2004)
10.1006/MGME.1998.2667
Modulation of intestinal permeability: an innovative method of oral drug delivery for the treatment of inherited and acquired human diseases.
A. Fasano (1998)
10.1007/BF03190262
From sticky stuff to sweet receptors — achievements, limits and novel approaches to bioadhesion
C. Lehr (2010)
10.1016/J.JCONREL.2005.09.032
Present and future of cell-penetrating peptide mediated delivery systems: "is the Trojan horse too wild to go only to Troy?".
E. Vivès (2005)
10.1042/BJ3200421
Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport.
F. Sharom (1996)
10.1016/S0169-409X(98)00057-X
Cyclodextrins in peptide and protein delivery.
Irie. (1999)
10.1016/j.jconrel.2008.08.001
Usefulness of cell-penetrating peptides to improve intestinal insulin absorption.
N. Kamei (2008)
10.1016/0024-3205(83)90656-2
Effects of sodium salicylate on epithelial cells of the rectal mucosa of the rat: a light and electron microscopic study.
P. Sithigorngul (1983)
The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
J. Radó (1976)
10.1007/s10552-012-0055-2
Critical review and synthesis of the epidemiologic evidence on formaldehyde exposure and risk of leukemia and other lymphohematopoietic malignancies
H. Checkoway (2012)
10.1016/j.colsurfb.2008.12.031
Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles.
Hong Yuan (2009)
10.2174/092986712799945003
Converting peptides into drug leads by lipidation.
L. Zhang (2012)
10.1016/S0168-3659(97)00136-3
Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates.
A. Bernkop-Schnürch (1998)
10.1016/J.IJPHARM.2006.02.044
Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system.
A. Bernkop-Schnürch (2006)
10.1016/S0928-0987(02)00221-X
Microbially triggered drug delivery to the colon.
V. Sinha (2003)
10.1007/BF00762348
Structures of archaebacterial membrane lipids
G. Sprott (1992)
10.1016/j.biomaterials.2011.10.021
Preactivated thiomers as mucoadhesive polymers for drug delivery
J. Iqbal (2012)
10.1155/2003/569283
Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen.
G. Sprott (2003)
10.1128/AEM.56.7.2146-2151.1990
Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora.
F. Rafii (1990)
10.1016/S0939-6411(00)00090-4
Hydrogels in pharmaceutical formulations.
N. Peppas (2000)
10.1021/JS980337N
Oral delivery of insulin using pH-responsive complexation gels.
A. Lowman (1999)
10.1023/A:1012040425146
Effect of Size and Charge on the Passive Diffusion of Peptides Across Caco-2 Cell Monolayers via the Paracellular Pathway
G. Pauletti (2004)
10.1016/j.biomaterials.2009.06.055
Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Lichen Yin (2009)
10.1016/0024-3205(82)90673-7
The absorption of insulin from various regions of the rat intestine.
M. Kidron (1982)
10.1111/J.1748-1716.1986.TB07861.X
In vitro intestinal transport of vasopressin and its analogues.
H. Vilhardt (1986)
10.1016/j.addr.2011.10.006
Oral colon delivery of insulin with the aid of functional adjuvants.
A. Maroni (2012)
10.1111/j.2042-7158.1996.tb05869.x
Effects of Polyacrylic Polymers on the Degradation of Insulin and Peptide Drugs by Chymotrypsin and Trypsin
J. M. Bai (1996)
10.1023/A:1015992819290
Enhancement of Colonic Drug Absorption by the Transcellular Permeation Route
M. Tomita (2004)
10.1016/j.tibtech.2009.07.009
Therapeutic application of peptides and proteins: parenteral forever?
Zuzana Antošová (2009)
Pharmaceutical approaches to colon targeted drug delivery systems.
M. Chourasia (2003)
10.1016/J.JCONREL.2006.12.022
A novel approach using functional peptides for efficient intestinal absorption of insulin.
M. Morishita (2007)
10.1023/A:1016086003070
Carrier-Mediated Intestinal Transport of Drugs
A. Tsuji (2004)
10.1016/0378-5173(94)90418-9
Oral delayed-release system for colonic specific delivery☆
A. Gazzaniga (1994)
10.1016/S0169-409X(01)00231-9
Oral drug absorption enhancement by chitosan and its derivatives.
M. Thanou (2001)
10.1021/JS960067D
How structural features influence the biomembrane permeability of peptides.
P. S. Burton (1996)
10.1016/0378-5173(96)04499-7
Cyclodextrins : Useful excipients for oral peptide administration ?
B. Haeberlin (1996)
10.1080/10611860410001693760
Use of Targeting Agents to Increase Uptake and Localization of Drugs to the Intestinal Epithelium
G. J. Russell-Jones (2004)
10.2174/138945012800675650
Sodium dependent multivitamin transporter (SMVT): a potential target for drug delivery.
A. D. Vadlapudi (2012)
10.1111/j.2042-7158.1993.tb05675.x
Stabilization of thymopentin and preservation of its pharmacological properties by 2‐hydroxypropyl‐β‐cyclodextrin
N. D. Brown (1993)
In vitro effects of long-chain acylcarnitines on the permeability, transepithelial electrical resistance and morphology of rat colonic mucosa.
E. Lecluyse (1993)
10.1016/J.ADDR.2007.04.007
Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
A. Almeida (2007)
10.1016/J.BBRC.2005.07.142
Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency.
J. Liang (2005)
10.1615/CRITREVTHERDRUGCARRIERSYST.V20.I23.30
Emerging trends in oral delivery of peptide and protein drugs.
R. Mahato (2003)
10.1517/17425247.4.5.547
Azo compounds in colon-specific drug delivery
M. Roldo (2007)
10.1006/BBRC.1993.1114
Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells.
P. S. Burton (1993)
10.1023/B:PHAM.0000008047.82334.7d
In Vivo Evaluation of an Oral Salmon Calcitonin-Delivery System Based on a Thiolated Chitosan Carrier Matrix
D. Guggi (2004)
10.1007/BF02209145
Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat
J. Pappenheimer (2005)
10.1016/J.EJPS.2006.10.003
Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
A. Trapani (2007)
10.2174/156720107780362339
Recent advances in protein and peptide drug delivery systems.
Dhirendra Kumar Malik (2007)
10.1016/S0168-3659(96)01599-4
Modified bile acids as carriers for peptides and drugs
W. Kramer (1997)
10.1002/JBM.A.10128
Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers.
H. Ichikawa (2003)
10.2147/IJN.S34991
Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine
Yan Chen (2012)
10.1517/14712598.2.3.287
Developments in the area of bioadhesive drug delivery systems
C. Lehr (2002)
10.1038/nrd1695
Protein drug stability: a formulation challenge
S. Frokjaer (2005)
Ultrastructural characteristics, secretory and phagocytotic activity of Paneth cells.
G. Répássy (1979)
10.1016/0378-5173(86)90069-4
Targeted enteral delivery of insulin to rats
E. Touitou (1986)
10.1016/J.ADDR.2007.05.012
Cyclodextrins as pharmaceutical solubilizers.
M. Brewster (2007)
Biodegradable microparticles as controlled release antigen delivery systems.
D. O'hagan (1991)
10.1023/A:1018920728800
Intestinal Permeability Enhancement: Structure-Activity and Structure-Toxicity Relationships for Nonylphenoxypolyoxyethylene Surfactant Permeability Enhancers
E. S. Swenson (2004)
Antidiuretic action of 1-deamino-(8-D-arginine)-vasopressin in unanesthetized rats.
I. Vavra (1974)
10.1517/17425247.1.1.141
Particle uptake by Peyer’s patches: a pathway for drug and vaccine delivery
Monjed Shakweh (2004)
10.1002/JPS.2600740408
Bioadhesive polymers as platforms for oral controlled drug delivery III: oral delivery of chlorothiazide using a bioadhesive polymer.
M. Longer (1985)
10.1097/00006454-198601001-00005
Anatomy and physiology of the gastrointestinal tract.
K. Graaff (1986)
Characterization of the hepatic canalicular membrane transport of a model oligopeptide: ditekiren.
H. Takahashi (1997)
10.1016/j.ejps.2010.12.005
Influence of polyunsaturated fatty acids on Cortisol transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model.
C. Navarro (2011)
10.1016/j.ijpharm.2012.05.033
Targeted lipid based drug conjugates: a novel strategy for drug delivery.
A. D. Vadlapudi (2012)
10.1023/A:1018929508018
Quantification and Visualization of the Transport of Octreotide, a Somatostatin Analogue, Across Monolayers of Cerebrovascular Endothelial Cells
U. Jaehde (2004)
10.1517/17425247.2012.697893
Thiomers and thiomer-based nanoparticles in protein and DNA drug delivery
S. Hauptstein (2012)
10.2174/138161209788682523
Current prodrug design for drug discovery.
Pei-Wen Hsieh (2009)
10.1016/S0378-5173(01)00579-8
Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat.
M. Kisel (2001)
10.1016/j.ejpb.2011.05.010
Enhanced transbuccal salmon calcitonin (sCT) delivery: effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation.
Dongho Oh (2011)
10.1016/0014-5793(93)80888-2
Functional expression of human P‐glycoprotein in Schizosaccharomyces pombe
K. Ueda (1993)
10.1002/CHIN.200202297
ChemInform Abstract: Peroral Route: An Opportunity for Protein and Peptide Drug Delivery
A. Sood (2002)
10.1023/A:1016246629130
Transport of Peptidomimetic Renin Inhibitors Across Monolayers of a Human Intestinal Cell Line (Caco-2): Evidence for Self-Enhancement of Paracellular Transport Route
E. Walter (2004)
10.1176/APPI.BOOKS.9781585623860.AS08
Principles of Pharmacokinetics and Pharmacodynamics
C. Devane (2009)
10.1002/1520-6017(200101)90:1<89::AID-JPS10>3.0.CO;2-A
Enhanced absorption of insulin and (Asu(1,7))eel-calcitonin using novel azopolymer-coated pellets for colon-specific drug delivery.
H. Tozaki (2001)
Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.
M. A. Hurni (1993)
10.1016/j.biomaterials.2011.12.038
Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.
Fang-Yi Su (2012)
10.1023/A:1012153011884
Enhanced Oral Uptake of Tomato Lectin-Conjugated Nanoparticles in the Rat
N. Hussain (2004)
10.1016/j.bmc.2009.02.043
Nanoparticles in cellular drug delivery.
A. H. Faraji (2009)
10.1080/02652040802485725
In vitro evaluation of chondroitin sulphate-chitosan microspheres as carrier for the delivery of proteins
K. Maculotti (2009)
10.1023/B:PHAM.0000022409.27896.d4
Contribution of Cholesterol and Phospholipids to Inhibitory Effect of Dimethyl-β-Cyclodextrin on Efflux Function of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 in Vinblastine-Resistant Caco-2 Cell Monolayers
Hidetoshi Arima (2004)
10.1023/A:1016444808000
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells
N. G. Schipper (2004)
Oral bioavailability and first-pass effects.
K. C. Kwan (1997)
10.1021/bp0101379
pH‐Sensitive Hydrogels as Gastrointestinal Tract Absorption Enhancers: Transport Mechanisms of Salmon Calcitonin and Other Model Molecules Using the Caco‐2 Cell Model
M. Torres-Lugo (2002)



This paper is referenced by
10.1016/j.neulet.2017.01.069
Computational comparison of a calcium-dependent jellyfish protein (apoaequorin) and calmodulin-cholesterol in short-term memory maintenance
G. A. Morrill (2017)
10.1021/jm500345q
A Fragment-Based Method to Discover Irreversible Covalent Inhibitors of Cysteine Proteases
Stefan G Kathman (2014)
10.1016/J.JDDST.2019.04.035
Challenge for oral delivery of middle-molecular drugs: Use of osmolarity-sensitive liposome as a drug carrier in the GI tract
K. Minami (2020)
10.1111/bcp.12557
Lessons learned from the clinical development of oral peptides
M. Karsdal (2015)
10.3390/polym9100485
Controlled Release of Lysozyme from Double-Walled Poly(Lactide-Co-Glycolide) (PLGA) Microspheres
R. H. Ansary (2017)
10.1039/d0bm01151g
Nano and microscale delivery platforms for enhanced oral peptide/protein bioavailability.
T. Tong (2020)
10.1002/EJLT.201600167
Enhanced oral bioavailability of quercetin by a new non‐aqueous self‐double‐emulsifying drug delivery system
Q. Wang (2017)
10.1002/2211-5463.12571
Intact anti‐LPS IgY is found in the blood after intragastric administration in mice
Xin Zhou (2019)
10.1080/10643389.2019.1619376
New approaches towards the discovery and evaluation of bioactive peptides from natural resources
N. Kang (2020)
10.1002/cem.2974
Machine learning‐based genetic evolution of antitumor proteins containing unnatural amino acids by integrating chemometric modeling and cytotoxicity analysis
Yongkang He (2018)
10.1111/cts.12567
Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development
Meric A. Ovacik (2018)
10.1517/17425247.2016.1160889
Enhancement of oral insulin bioavailability: in vitro and in vivo assessment of nanoporous stimuli-responsive hydrogel microparticles
N. Ahmad (2016)
10.1016/J.INDCROP.2016.02.023
Characterization of concanavalin A-conjugated resistant starch acetate bioadhesive film for oral colon-targeting microcapsule delivery system
Bie Pingping (2016)
10.1208/s12249-017-0834-x
Improvement of Oral Bioavailability of Lopinavir Without Co-administration of Ritonavir Using Microspheres of Thiolated Xyloglucan
A. Madgulkar (2017)
10.1016/J.PMATSCI.2017.05.001
Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals
Francisca Araújo (2017)
10.1158/1535-7163.MCT-17-1156
A Short BRCA2-Derived Cell-Penetrating Peptide Targets RAD51 Function and Confers Hypersensitivity toward PARP Inhibition
Anika Trenner (2018)
10.1533/9781908818683.311
Summary and future perspectives for oral insulin delivery
T. A. Sonia (2015)
10.1016/B978-0-12-804304-2.00016-0
Enhanced nutrient delivery through nanoencapsulation techniques: the current trend in food industry
Ilaiyaraja Nallamuthu (2017)
10.1016/j.jconrel.2013.12.034
Oral absorption mechanism and anti-angiogenesis effect of taurocholic acid-linked heparin-docetaxel conjugates.
Zehedina Khatun (2014)
10.1007/s13233-019-7042-3
Efficient Mucosal Immunization by Mucoadhesive and pH-Sensitive Polymeric Vaccine Delivery System
L. Xing (2019)
10.1039/c8bm01485j
Enhanced oral absorption of insulin using colon-specific nanoparticles co-modified with amphiphilic chitosan derivatives and cell-penetrating peptides.
F. Guo (2019)
10.1002/chem.201501270
Enantiomeric cyclic peptides with different Caco-2 permeability suggest carrier-mediated transport.
U. K. Marelli (2015)
10.1016/j.bmc.2016.05.069
Synthesis, photophysical properties of triazolyl-donor/acceptor chromophores decorated unnatural amino acids: Incorporation of a pair into Leu-enkephalin peptide and application of triazolylperylene amino acid in sensing BSA.
S. Bag (2016)
10.3390/md18080390
Advances in the Study of Marine Products with Lipid-Lowering Properties
J. Zhao (2020)
10.1016/j.peptides.2020.170347
Adrenomedullin – Current perspective on a peptide hormone with significant therapeutic potential
J. Fischer (2020)
Colon Targeted Protein Nanoparticles loaded Suppositories : Effective against Intestinal Parasites
Swati Chauhan (2020)
10.4172/0975-0851.1000372
Investigation of Intestinal Absorption Enhancers: Individual vs. Blends with the Carbamoylphosphonate JS403
Reut Bitton (2018)
10.1042/BSR20182028
Mucosal immune responses induced by oral administration recombinant Bacillus subtilis expressing the COE antigen of PEDV in newborn piglets
Jialu Wang (2019)
10.1002/cbic.201700350
Intramolecular Thioether Crosslinking to Increase the Proteolytic Stability of Affibody Molecules
A. Nilsson (2017)
10.1016/j.ijpharm.2018.07.008
Challenges for pulmonary delivery of high powder doses
I. Sibum (2018)
10.1007/s11095-015-1788-x
Oxaprozin-Loaded Lipid Nanoparticles towards Overcoming NSAIDs Side-Effects
José Lopes-de-Araújo (2015)
10.1007/s13346-020-00822-4
Phospholipid complex-loaded self-assembled phytosomal soft nanoparticles: evidence of enhanced solubility, dissolution rate, ex vivo permeability, oral bioavailability, and antioxidant potential of mangiferin
D. Telange (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar